Curi Capital Buys New Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)


Share on StockTwits

Curi Capital purchased a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,000 shares of the real estate investment trust’s stock, valued at approximately $36,000.

A number of other large investors have also recently made changes to their positions in the business. BlackRock Inc. lifted its stake in shares of Omega Healthcare Investors by 1.5% in the 4th quarter. BlackRock Inc. now owns 27,113,630 shares of the real estate investment trust’s stock valued at $984,766,000 after purchasing an additional 407,234 shares in the last quarter. Daiwa Securities Group Inc. raised its holdings in Omega Healthcare Investors by 4,508.5% in the fourth quarter. Daiwa Securities Group Inc. now owns 3,080,335 shares of the real estate investment trust’s stock valued at $111,878,000 after buying an additional 3,013,495 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Omega Healthcare Investors by 9.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,591,264 shares of the real estate investment trust’s stock valued at $94,115,000 after buying an additional 232,589 shares in the last quarter. Amundi Pioneer Asset Management Inc. grew its stake in Omega Healthcare Investors by 213.9% during the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 2,447,939 shares of the real estate investment trust’s stock worth $88,941,000 after buying an additional 1,668,136 shares during the period. Finally, Norges Bank purchased a new stake in Omega Healthcare Investors during the fourth quarter worth approximately $83,272,000. Institutional investors own 69.46% of the company’s stock.

Several equities analysts recently weighed in on OHI shares. Jefferies Financial Group upgraded shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating and lifted their target price for the company from $35.00 to $40.00 in a report on Wednesday, January 13th. Mizuho downgraded Omega Healthcare Investors from a “buy” rating to a “neutral” rating and set a $36.00 target price for the company. in a research report on Wednesday, January 13th. Wells Fargo & Company upgraded Omega Healthcare Investors from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $33.00 to $39.00 in a report on Thursday, December 10th. Smith Barney Citigroup upped their price target on Omega Healthcare Investors from $30.00 to $37.00 in a report on Tuesday, December 15th. Finally, Zacks Investment Research downgraded shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research report on Thursday. One analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company. Omega Healthcare Investors has an average rating of “Buy” and an average price target of $36.03.

In related news, COO Daniel J. Booth sold 25,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 30th. The stock was sold at an average price of $37.11, for a total transaction of $927,750.00. Following the sale, the chief operating officer now directly owns 147,530 shares of the company’s stock, valued at approximately $5,474,838.30. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders bought a total of 1,500 shares of company stock valued at $55,695 over the last quarter. Company insiders own 1.16% of the company’s stock.

OHI opened at $39.16 on Thursday. The company has a market capitalization of $9.08 billion, a P/E ratio of 56.75, a PEG ratio of 2.47 and a beta of 1.03. The company has a 50-day moving average of $37.41 and a 200-day moving average of $35.12. The company has a debt-to-equity ratio of 1.31, a quick ratio of 3.40 and a current ratio of 3.40. Omega Healthcare Investors, Inc. has a 1-year low of $23.89 and a 1-year high of $39.19.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Thursday, February 4th. The real estate investment trust reported $0.27 EPS for the quarter, missing the Zacks’ consensus estimate of $0.79 by ($0.52). Omega Healthcare Investors had a return on equity of 3.78% and a net margin of 17.99%. As a group, sell-side analysts expect that Omega Healthcare Investors, Inc. will post 3.15 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, February 16th. Stockholders of record on Monday, February 8th were issued a $0.67 dividend. The ex-dividend date of this dividend was Friday, February 5th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.84%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 87.30%.

About Omega Healthcare Investors

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Recommended Story: Why Net Income is Important to Investors

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.